One of the key reasons patient advocates cite for preferring GLP-1 therapies, beyond clinical benefits, is their convenienceas these drugs are administered once weekly, unlike insulin, which requires daily injections
Dietary Adjustments: Eating smaller, more frequent meals and avoiding high-fat/fried foods
Drucker DJ (2024): Efficacy and Safety of GLP-1 Medicines for Type 2 Diabetes and Obesity
Add a handful of spinach
Additionally, proponents argue that even sub-therapeutic doses might provide modest improvements in appetite regulation and weight management outcomes that could benefit Hashimoto's patients struggling with metabolic complications
Other state regulated markets Table 2 shows the status of coverage of Wegovy for obesity in four state-regulated health insurance markets: Medicaid, state-employee plans, the small group market, and the individual market